Recent News

• 09.23.2025 - FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility
• 09.23.2025 - FDA Issues Complete Response Letter (CRL) for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) Solely Related to Observations Identified at Catalent Indiana LLC Fill-Finish Facility
• 09.18.2025 - Etzer Darout, PhD
• 09.18.2025 - Etzer Darout, PhD
• 09.16.2025 - Mani Foroohar, M.D.
• 09.16.2025 - Mani Foroohar, M.D.
• 09.12.2025 - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.12.2025 - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.15.2025 - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.15.2025 - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 09.23.2025 - 8-K Current report
• 09.23.2025 - EX-99.1 EX-99.1
• 09.22.2025 - 144 Report of proposed sale of securities
• 09.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.16.2025 - 144 Report of proposed sale of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors